NEW YORK — Private equity firm GTCR said on Tuesday that its Cole-Parmer business has acquired ZeptoMetrix, a maker of quality control standards and verification panels used in infectious disease molecular diagnostic testing.
Financial and other terms of the deal were not disclosed.